NNC-39-0028

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNNC-39-0028
Drug Alias Name2,3 diamino-phenazineNNC-39-0028
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdvanced glycation metabolite synthesis inhibitors
TargetsUpdating
Therapy Area/IndicationsDiabetes Complications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovo Nordisk A/S
Active IndicationsN/A
Inactive IndicationsDiabetes Complications

Other Information

ATC CodeN/A
Related LinksN/A